Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: Comment on the editorial by Buyon et al
Open Access
- 10 January 2003
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (1), 280-281
- https://doi.org/10.1002/art.10716
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune GlobulinNew England Journal of Medicine, 2001
- Anti-Ro/SSA antibodies and congenital heart block: Necessary but not sufficientArthritis & Rheumatism, 2001
- The rate of recurrence of isolated congenital heart block: A population-based studyArthritis & Rheumatism, 2001
- Short- and Long-Term Outcome of Children With Congenital Complete Heart Block Diagnosed In Utero or as a NewbornPublished by American Academy of Pediatrics (AAP) ,2000
- Fetal Treatment of Congenital Heart Block Ascribed to Anti-SSA Antibody: Case Reports with Observation of Cardiohemodynamics and Review of the LiteratureAmerican Journal of Reproductive Immunology, 1999
- NEONATAL LUPUS SYNDROMESRheumatic Disease Clinics of North America, 1997
- In Utero identification and therapy of congenital heart blockLupus, 1995
- Congenital heart block: Successful prophylactic treatment with intravenous gamma globulin and corticosteroid therapyAmerican Journal of Obstetrics and Gynecology, 1991